Bioprocess Containers Market Set to Register a CAGR of 21.35% and Reach US$ 19.87 Billion by 2031 – Growth Plus Reports

Newark, New Castle, USA, April 18, 2023 (GLOBE NEWSWIRE) -- According to a recent Growth Plus Reports assessment, the Bioprocess Containers Market is estimated to reach US$ 19.87 billion by 2031, with a revenue CAGR of 21.35%. The report examines the vital growth strategies, factors and prospects, competitive scenarios, shifting industry trends, market dynamics, data and forecasts, and ideal investment regions.

Key Takeaways:

• Increased demand for biopharmaceuticals and personalized medicine will drive market revenue growth.

• North America will register the fastest revenue growth in the global bioprocess containers market.

• The increasing use of single use technologies will fuel the growth of the market. 

Request a Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/bioprocess-containers-market/8638

Bioprocess Containers Market Scope

Market Drivers
The increasing demand for biopharmaceuticals and personalized medicine is the major factor driving the revenue growth of the global bioprocess containers market. Furthermore, the increased adoption of single-use technologies contribute to the market's revenue growth rate. 

Market Segmentation
Growth Plus Reports has analyzed the global bioprocess containers market from four perspectives: Type of Containers, Application, End User, and Region.

Type of Containers Segmentation: Based on the type of containers, the global bioprocess containers market is segmented into 2D bioprocess containers, 3D bioprocess containers, and others. The segment dominates the market with the largest revenue share because these containers are widely used to transport huge numbers of medical goods and precursors, and also to harvest cells, and they aid in biopharmaceutical manufacturing by assisting with fluid management, media preparation, and storage.

Application Segmentation: Based on the application, the global bioprocess containers market is segmented into upstream, downstream, and process development. The segment dominates the market because bioprocess containers are important in the upstream process of biopharmaceutical production because they provide a sterile environment for cell growth and the generation of biomolecules.

End User Segmentation: Based on the end user, the global bioprocess containers market is segmented into pharmaceutical & biopharmaceutical companies, academic & research institutes, and CROs & CMOs. The pharmaceutical & biopharmaceutical companies segment dominates the market because bioprocess containers are necessary for the safe storage and transportation of biopharmaceutical products.
  
Regional Growth Dynamics
Based on the region, the global bioprocess containers market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is expected to dominate the global bioprocess containers market with the largest revenue share. The dominance of North America can be attributed to the growing demand for biopharmaceuticals, the increasing adoption of single-use technologies, the increasing number of biopharmaceutical companies, the need for cost-effective manufacturing processes, the growing demand for personalized medications, the rising prevalence of chronic diseases, and the need for advanced treatment options.

Request for Customization – https://www.growthplusreports.com/inquiry/customization/bioprocess-containers-market/8638

Competitive Landscape
The prominent players in the global bioprocess containers market are:

• Thermo Fisher Scientific Inc.
• Cytiva
• Saint-Gobain S.A
• Lonza Group AG
• Avantor Inc
• Merck KGaA
• Sartorius AG
• CellBios Healthcare and Lifesciences Pvt Ltd
• Cole-Parmer Instrument Co.
• Biomass Sensor Singapore Pte

The bioprocess containers market is extremely competitive, with many players involved. Market leaders increasingly use mergers, collaborations, and acquisitions to increase their market share and launch new drugs and products.

Recent developments:

• Thermo Fisher Scientific announced the launch of a single-use technology manufacturing facility in Ogden, Utah, in April 2022. It boosts the capability for producing high-quality technologies and materials essential for developing novel vaccines and breakthrough treatments, indicating increased bioprocess container production.
• Dow announced a collaboration with Sartorius and Südpack Medica in February 2022 to develop bioprocessing bags for properly producing and exporting coronavirus vaccines abroad.

Table of Content

1. INTRODUCTION
   1. Market Ecosystem
   2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
   3. Currency Used in the Report
2. RESEARCH METHODOLOGY 
   1. Research Approach
   2. Data Collection Methodology
   3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
   4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
   5. Market Forecasting Model
   6. Limitations and Assumptions
3. PREMIUM INSIGHTS
   1. Current Market Trends (COVID-19 Perspective)
   2. Key Players & Competitive Positioning (2022)
4. MARKET DYNAMICS
   1. Drivers
   2. Restraints/Challenges
   3. Opportunities
5. GLOBAL BIOPROCESS CONTAINERS MARKET - ANALYSIS & FORECAST, BY TYPE
   1. 2D Bioprocess Containers
   2. 3D Bioprocess Containers
   3. Others                        
6. GLOBAL BIOPROCESS CONTAINERS MARKET - ANALYSIS & FORECAST, BY APPLICATION
   1. Upstream Process 
   2. Downstream Process
   3. Process Development
7. GLOBAL BIOPROCESS CONTAINERS MARKET - ANALYSIS & FORECAST, BY END USER 
   1. Pharmaceutical & Biopharmaceutical Companies
   2. Academic & Research Institutes 
   3. CROs & CMOs

BIOPROCESS CONTAINERS MARKET TOC

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8638

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on 'Strategic Developments' registered by leading players of the market

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• 'Business Profile' of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at - https://www.growthplusreports.com/report-store

Browse Latest Healthcare Related Reports:

Pneumonia Testing Market by Type (Bacterial, Viral), Test Type (Blood Test, Sputum Test), Method (Immunodiagnostic, Molecular Diagnostics), Technology (Enzyme-Linked Immunosorbent Assay (ELISA), Immunofluorescence), End User (Hospitals, Diagnostic Centers) - Global Outlook and Forecast 2023-2031

Positive Expiratory Pressure Devices Market by Product Type (Face Mask PEP Devices, Mouthpiece PEP Devices), Application (Atelectasis, Bronchiectasis), End User (Hospitals & Clinics, Ambulatory Surgical Centers) – Global Outlook & Forecast 2023-2031

Aortic Valve Replacement Devices Market by Surgery (Open Surgery, Minimally Invasive Surgery), Product (Transcatheter Aortic Valve, Suture-less Valve), End User (Hospitals, Ambulatory Surgery Centers) - Global Outlook and Forecast 2023-2031

Antiplatelet Drugs Market by Drug Class (Irreversible Cyclooxygenase Inhibitors, Thromboxane inhibitors), Route of Administration (Oral, Parenteral), Indications (Acute Coronary Syndrome, Acute Ischemic Stroke) - Global Outlook and Forecast 2023-2031

Pharmaceutical Quality Management Systems Market by Deployment (On-cloud, On-premises), Solution Type (Audit Management, Document Management), End User (Pharmaceutical Companies, Contract Research Organizations) – Global Outlook & Forecast 2023-2031

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.